NEWS
Bionomics looks to Nasdaq as its route to growth

MELBOURNE: Peter Thiel-backed anxiety medication developer Bionomics says it’s considering a Nasdaq listing.
The ... read more
MELBOURNE: Peter Thiel-backed anxiety medication developer Bionomics says it’s considering a Nasdaq listing.
The ... read more